Cargando…
421 Specific cephalosporin antibiotics deplete tumor PD-L1 to inhibit DNA damage sensing and sensitize to Chk1 inhibitors in vivo
OBJECTIVES/GOALS: Tumor PDL1 signals to immune cells for tumor immune evasion but has cell-intrinsic signals that promote tumor virulence. We identify novel tumor PDL1 depleting drugs (PDDs) to interrupt tumor-intrinsic PDL1 signals and sensitize tumors to targeted therapy in vitro and in vivo. METH...
Autores principales: | Murray, Clare, Kornepati, Anand, Padron, Alvaro, Deng, Yilun, Garcia, Myrna, Bai, Haiyan, Curiel, Tyler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209123/ http://dx.doi.org/10.1017/cts.2022.245 |
Ejemplares similares
-
Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents
por: Murray, Clare, et al.
Publicado: (2022) -
416 LRP1 as a modulator of hippocampal neurogenesis and neurodegeneration
por: Dietert, Kristi, et al.
Publicado: (2022) -
362 Group Model Building to characterize the experiences of older adults with type 1 diabetes (T1D) with continuous glucose monitoring (CGM) therapy and uncover suboptimal response patterns
por: Kahkoska, Anna R, et al.
Publicado: (2022) -
339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes.
por: Bruggeman, Brittany S, et al.
Publicado: (2022) -
241 Utilizing real-world evidence to increase efficiency of randomized controlled trials with application to repurposed therapeutics for COVID-19
por: Haine, Lillian M F, et al.
Publicado: (2022)